Last reviewed · How we verify

NCT05828602

Pulmonary Rehabilitation Through Tele Rehabilitation for COPD in Pakistan

Completed NA Last updated 10 July 2023
What this trial tests

NA trial testing Conventional treatment in COPD in 40 participants. Completed in 1 July 2023.

Timeline
20 April 2023
Primary endpoint
1 July 2023
1 July 2023

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date20 April 2023
Primary completion1 July 2023
Estimated completion1 July 2023
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

40 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the feasibility of Tele-rehabilitation vs traditional center-based pulmonary rehabilitation for people with chronic obstructive pulmonary disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Conventional treatment

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing